Brief: Biophytis Receives Notice Of Delisting From Nasdaq And Announces It Will Request A Hearing Before The Nasdaq Hearings Panel
27/10/2023 22:03
Oct 27 (Reuters) - Biophytis SA ALBPS.PA :
* BIOPHYTIS RECEIVES NOTICE OF DELISTING FROM NASDAQ AND
ANNOUNCES
IT WILL REQUEST A HEARING BEFORE THE NASDAQ HEARINGS PANEL
Source text for Eikon: ID:nEQ7tL93Ja
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon